FDA Approved: OLOPATADINE HYDROCHLORIDE — Supplemental Application (GLENMARK THERAPEUTICS INC., USA)

View source ↗

Summary

The FDA approved Glenmark Therapeutics' supplemental application for olopatadine hydrochloride ophthalmic solution, updating the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis

Drugs mentioned

• OLOPATADINE HYDROCHLORIDE OPHTHALMIC SOLUTION (olopatadine hydrochloride ophthalmic solution)

Snippet

SUPPL AP for OLOPATADINE HYDROCHLORIDE (OLOPATADINE HYDROCHLORIDE OPHTHALMIC)